Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Name: Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
Published: 2022
License: Public Domain

Adverum Biotechnologies, Inc. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

neovascular age-related macular degeneration, aflibercept, best corrected visual acuity, adverum, advm, advm-022, advm-022-11, age-related macular degeneration, wet macular degeneration, wet amd, choroidal neovascularization, cnv

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 829980
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.